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Infections such as measles are characterized by a severe
inflammatory response, increased production of the inflammatory cytokines, including interleukin-6 (IL-6), and
decreased concentrations of circulating retinol (i.e., hyporetinolemia) (1). Measles-induced hyporetinolemia has
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been associated with increased morbidity and mortality
and the development of xerophthalmia in children from
areas where vitamin A (VA) may or may not be a public
health problem (2, 3). Moreover, supplementation with
large doses of VA (200,000 IU of VA on 2 consecutive days)
reduced these children’s morbidity, mortality, and risk of
blindness (4). Although this hyporetinolemia has been
well documented and is postulated as mediating measles
morbidity and mortality, little is known about the mechanism leading to decreased plasma retinol concentrations
or its consequences.
Several hypotheses have been proposed to explain
inflammation-induced hyporetinolemia, including decreased intake, malabsorption, direct loss, increased requirement, and impaired utilization (5). The possible
underlying mechanisms include the following: 1) impaired
absorption or cleavage of dietary proformed carotenoids
or preformed VA (6); 2) increased utilization of VA subsequent to its immune-potentiating role during infections
(7); 3) increased glomerular filtration followed by an impaired reabsorption in the proximal tubule, leading to
retinol and retinol binding protein (RBP) being excreted
in urine (8); and 4) reduced hepatic synthesis of RBP and
decreased secretion of retinol into plasma (9, 10). We have
shown previously that inflammation induced with lipopolysaccharide (LPS) or recombinant human interleukin-6
(rhIL-6) decreases the availability of RBP and increases
the concentrations of hepatic retinol or retinyl esters
(9, 11). However, the effect(s) of this decrease in RBP and
the increase in hepatic VA on the kinetics and dynamics of
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Abstract Vitamin A (VA) kinetics was studied in rats with
marginal VA stores before, during, and after inflammation.
Rats received orally [11,12-3H(N)]retinol ([3H]VA; day 0),
and inflammation was induced on day 21 with lipopolysacchride (LPS) for 3 days (n 5 5) or recombinant human
interleukin-6 (rhIL-6) for 7 days (n 5 5). Both the fraction of
[3H]VA and retinol concentrations in plasma were reduced
significantly by LPS or rhIL-6. Compartmental analysis using
the Windows version of Simulation, Analysis, and Modeling
software was applied to group mean data, and non-steadystate models were developed. After absorption, VA kinetics
was described by a three-compartment model that included
plasma, kidney/interstitium, and liver/carcass. Four mechanisms decreasing plasma retinol were investigated: increased
urinary excretion, increased irreversible loss, increased
movement into interstitium, and decreased hepatic mobilization. Modeling demonstrated that a 79% reduction in
hepatic mobilization of retinol (from 4.3 to 0.9 nmol/h) by
15 h after LPS best accounted for the observed changes in
plasma VA kinetics (sum of squares 5 9.05 3 10207). rhIL-6
caused an earlier reduction (75% by 5.6 h). These models
predicted a return to control values by 10 days after inflammation. If prolonged, inflammation-induced hyporetinolemia can render hepatic retinol unavailable to extrahepatic
tissues, possibly leading to their impaired function, as observed in VA-deficient children with measles infection.—
Gieng, S. H., M. H. Green, J. B. Green, and F. J. Rosales.
Model-based compartmental analysis indicates a reduced
mobilization of hepatic vitamin A during inflammation in
rats. J. Lipid Res. 2007. 48: 904–913.

whole-body retinol flux during inflammation has not been
studied previously.
In previous studies, model-based compartmental analysis has been fruitfully applied to describe and quantify the
dynamics of whole-body VA metabolism and to understand
the impact of various treatments on VA kinetics (12–17). A
major observation from this type of analysis has been the
extensive recycling of VA (i.e., retinol and retinyl esters)
before it is irreversibly lost (18). Using these techniques,
it was determined that the recycling of VA is affected by VA
status (i.e., deficiency vs. sufficiency) (19) and by nutritional and chemical stressors, including iron deficiency
(20), N-(4-hydroxyphenyl)retinamide treatment (21), and
2,3,7,8-tetrachlorodibenzo-p-dioxin exposure (22). By
comparing model parameters in different physiological,
nutritional, or pathological states, the technique provides
information on the sites of impact of various treatments.
Our objective was to use mathematical modeling and modelbased compartmental analysis to assess the potential mechanisms responsible for inflammation-induced hyporetinolemia.

Materials
Unless noted otherwise, chemical reagents were purchased
from EMD Chemicals (Gibbstown, NJ), Fisher Chemicals
(Pittsburgh, PA), Mallinckrodt Baker (Phillipsburg, NJ),
Pharmco (Brookfield, CT), and Sigma (St. Louis, MO). rhIL-6
was purchased from Austral Biologicals (San Ramon, CA), and
LPS derived from Pseudomonas aeruginosa was purchased from
Calbiochem (San Diego, CA). Osmotic minipumps were purchased from Alzet (Cupertino, CA). Trimethylmethoxyphenyl
(TMMP)-retinol was a generous gift from Hoffmann-La Roche
(Basel, Switzerland). [11,12-3H(N)]retinol ([3H]VA) was obtained from NEN Life Science Products (lot No. 3354284;
Boston, MA). To protect samples from photooxidation, all VA
analyses were conducted under fluorescent lights shaded with an
ultraviolet light-blocking film (Sydlin, Inc., Lancaster, PA).

Animals and sample collection
Male pathogen-free Sprague-Dawley rats were purchased from
Charles River Breeding Laboratories (Kingston, NY). All experi-

Pilot experiment
A pilot study was initially conducted to establish parameters to
use in the kinetic study, including the adequate oral dose of
tracer ([3H]VA), the time for the tracer to equilibrate with body
pools of VA, and the time the rats needed to recover from
experimentally induced inflammation. At 2 months of age,
VA-sufficient rats (n 5 4) were given an oral dose of [3H]VA
dissolved in 0.29 g of soybean oil (1.44 3 105 Bq/dose) using
a polyethylene tube, a 21 gauge needle, and a 1 ml syringe.
Twenty-one days later, VA kinetics was perturbed by continuous
administration of either LPS (n 5 2; 500 mg/kg/day) for 3 days
or rhIL-6 (n 5 2; 65 mg/kg/day) for 7 days via osmotic minipumps implanted subcutaneously. Sixteen to 19 d later, each rat
was euthanized by carbon dioxide asphyxiation, and terminal
blood and livers were collected and frozen until analyses.

Kinetic study
Upon arrival, weanling rats (n 5 22) were fed 8.02 mmol retinyl
palmitate/kg diet for 7 days. They were then fed 2.44 mmol
retinyl palmitate/kg diet for the remainder of the study. The
first diet was intended to increase their liver stores to ?200 mg
(?700 nmol), and the second diet provided the rats with ?14 mg
retinol equivalents/day assuming consumption of ?20 g diet/day.
These levels of VA were based on estimates from a previous study
(23). The diet was made in the laboratory, and its composition
(except VA) was based on the American Institute of Nutrition-93
rodent diet formula for growth, pregnancy, and lactation (24).
At 7 weeks of age, 14 rats received an oral dose of [3H]VA
in soybean oil (9.3 3 105 Bq/dose) (Fig. 1). After equilibration of

Fig. 1. Experimental design of the main kinetic study. Adult male Sprague-Dawley rats were administered
[11,12-3H(N)]retinol ([3H]VA) orally (day 0, n 5 14). On day 21, rats were continuously treated with PBS
(3 days, n 5 2; 7 days, n 5 2), lipopolysaccharide (LPS; 3 days, n 5 5), or recombinant human interleukin-6
(rhIL-6; 7 days, n 5 5). Twenty-six days later (day 54), rats were euthanized and tissues were collected for
analyses. Blood samples (n 5 34–36; 0.25 ml) were serially collected from 2 h to 54 days. On days 0 and 21,
nondosed rats were euthanized to determine hepatic concentrations of vitamin A (VA; n 5 4/time).
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MATERIALS AND METHODS

mental procedures were approved by the Institutional Animal
Care and Use Committee at Pennsylvania State University. All
animals were housed with a 12 h light/dark cycle at 22jC and
provided diet and water ad libitum.
During kinetic studies, serial blood samples were collected
from 2 h to 54 days after [3H]VA administration. Blood was
collected from a caudal blood vessel (n 5 34–36; 0.25 ml) into
heparinized tubes (20 U heparin/ml blood). After centrifugation
(Sorvall RT6000B, H-1000B rotor) at 1,300 g for 15 min at 4jC,
plasma was collected, purged with nitrogen gas, and stored at
280jC until analysis. At the end of each experiment, rats were
killed by carbon dioxide asphyxiation. Terminal blood was drawn
via cardiac puncture into heparinized syringes. The animals were
then perfused with PBS, and livers and carcasses were collected
immediately by dissection, blotted, and frozen at 280jC and
220jC, respectively, until analysis.

tracer with whole-body VA pools, inflammation was induced
on day 21 with LPS (n 5 5; 500 mg/kg/day) for 3 days or rhIL-6
(n 5 5; 65 mg/kg/day) for 7 days via osmotic minipumps implanted subcutaneously. PBS was similarly given to controls for
3 days (n 5 2) or 7 days (n 5 2). At 0 and 21 days, additional rats
were euthanized to determine baseline and perturbation liver VA
concentrations (n 5 4/day). We selected LPS and rhIL-6 at these
doses because in our previous experiments (9, 11) we demonstrated that these doses induced inflammation without septicemia or renal failure, and they allowed us to examine the effects
of the acute-phase response of inflammation on the distribution
of VA and RBP in various tissues (9, 11). Additionally, rhIL-6
induced and maintained the acute-phase response of inflammation for up to 7 days without causing metabolic alterations or
reducing food intake (11).

Plasma and tissue analyses

Kinetic analysis
Model-based compartmental analysis was performed to develop
the simplest compartmental model compatible with tracer and
tracee data for plasma, liver, and carcass. The Windows version of
the Simulation, Analysis, and Modeling software (WinSAAM) (26)
was used for this purpose. First, the fraction of the oral dose
(fdose) in plasma at each time was estimated as dpm/ml in plasma
divided by administered dpm/estimated plasma volume (ml).
Plasma volume was estimated from body weight on day 25 of the
study (g) 3 0.038 ml plasma/g body weight (27).
To determine a model of VA metabolism before the perturbation caused by inflammation, normalized plasma data before
21 days were used. Values in each group (PBS, LPS, and rhIL-6)
were averaged to develop a preperturbation control model. Because the tracer was administered orally, an absorption/processing
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Statistical analysis
Descriptive data are presented as group means 6 SD. Data
were compared statistically using a Student’s unpaired t-test in
Microsoft Excel (2003 version) with P < 0.05 considered significant. The data for each treatment group (PBS, LPS, and rhIL-6)
were averaged for the kinetic analyses using WinSAAM (26).
Because compartmental modeling was done using group mean
data at each time, it was not possible to compare kinetic parameters statistically between groups. With the present study design
(preperturbation, perturbation, and postperturbation portions
of the model), each group of rats served as its own control (i.e.,
data before the perturbation). For weighting purposes, model
development based on observed data was set at a fractional standard deviation of 5% (SD/mean). The weighted sum of squares
represents the sum of the squared differences between observed
and model-predicted data points and was used to evaluate the
closeness of the predicted model to the observed data. Akaike’s
Information Criterion (AIC) was calculated for each model to
determine which had the lowest number (the best fit) for the
observed data (29).

RESULTS
Pilot experiment
In the pilot study, determination of labeled retinol in
the plasma of rats indicated the successful administration
and absorption of the tracer dose. Both LPS- and rhIL-6treated rats showed similar tracer response profiles in
plasma up to ?21 days. When the inflammation-inducing
agents were administered beginning on day 21, there was
an ?63% reduction in plasma tracer levels over 6 days in
the LPS-treated rats, whereas rhIL-6-treated rats had an
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For analysis of tritium in plasma samples, retinol was extracted
into hexane as described previously (11, 25), solvent was removed
under a stream of nitrogen, and 5 ml of scintillation solution
(Betamax ES; ICN Biomedicals) was added to each liquid scintillation vial. Tritium content of each sample was determined using
a Beckman Liquid Scintillation System (LS 3801). Each sample was counted to a 2s error level of 1% after a counting efficiency calibration was performed using a quench curve, and dpm
was determined.
Retinol concentrations in plasma for 17 of the samples collected over the experimental period for each rat were determined by HPLC (Hewlett-Packard 1100) using TMMP-retinol as
an internal standard (25) after extraction with hexane. The
reverse-phase system included a Zorbax Eclipse XDB-C8 (5 mm,
4.6 3 150 mm) with a C8 guard column (Agilent Technologies,
Wilmington, DE) and a multiple wavelength ultraviolet light detector. Retinol was detected at 325 nm.
Frozen livers were lyophilized and analyzed for VA mass and/
or radioactivity. Aliquots of freeze-dried livers were saponified
using a modified method described previously (16). Triplicate
weighed aliquots of liver (?0.15 g) were combined with 1.0 ml of
ethanol containing 0.1% pyrogallol as an antioxidant. TMMPretinol (internal standard) and 0.5 ml of 60% aqueous KOH were
then added. Samples were purged with nitrogen and allowed to
incubate at 60jC for 60 min. After saponification, the lipid fraction was extracted three times using 5 ml of hexane containing
5 mg butylated hydroxytoluene/ml and 1 ml of distilled water. A
portion of the extract was dried under a stream of nitrogen in
liquid scintillation vials, 10 ml of scintillation solution was added,
and its radioactivity was determined. A separate aliquot of the
extract was dried under nitrogen, reconstituted in methanol, and
analyzed for retinol by HPLC as described above.

model first needed to be developed to account for this (28). After the absorption model was developed, a three-compartment
model was developed, similar to a previously published conceptual model (23). Fractional transfer coefficients [L(I,J)s, or the
fraction of compartment J that is transferred to compartment
I per unit time] were then determined.
To account for the administration of the perturbing doses of
PBS, LPS, or rhIL-6, a time interrupt was introduced into plasma
data at day 21. Moreover, a second independent variable, theta,
was introduced to allow for the adjustment of parameters during
the perturbation. Fractional transfer coefficients before day 21
were fixed. After day 21, the fractional transfer coefficients were
adjusted one at a time to find the minimal change necessary to fit
the observed data obtained after the perturbations.
The LPS data were used to develop an initial model. Four
potential causes explaining LPS-induced hyporetinolemia were
investigated (increased urinary excretion, increased irreversible
loss, increased movement into interstitial fluid, and decreased
hepatic mobilization of retinol) by adjustment of kinetic parameters believed to represent these changes. Best-fit models were
determined based on a statistically close fit of the model to the
observed data (sum of squares). A two-part difference equation
was used to represent the changes in one parameter. This equation used the second independent variable feature of WinSAAM
to represent the time since the beginning of the perturbations.
Changes to parameters in the model were as follows: 1) increased
urinary excretion, added L(10,6) (see Table 2, Fig. 5 below); 2) increased irreversible loss, adjusted L(10,7); 3) increased movement into interstitial fluid, adjusted L(6,5) and L(5,6); and 4)
decreased hepatic mobilization of retinol, adjusted L(5,7).

?89% reduction over 10 days. Tracer in plasma for both
treatment groups returned to preperturbation levels after
inflammation. However, it was apparent that the postperturbation time after rhIL-6 treatment was not long
enough to clearly see the postinflammation and terminal
data. Therefore, the subsequent experiment was extended
an additional 2 weeks.

Dynamics of [3H]VA (tracer)
After calculating the fdose in plasma for each rat at
each time point, the arithmetic means at each time point
were calculated for each treatment group. These data were
plotted on semilogarithmic graphs. For each group, there
was a rapid initial increase in tracer that peaked at 7.1–
8.4% of the dose by 6 h. The fdose declined thereafter and
reached a terminal slope by ?10 days after oral tracer
administration. This terminal slope remained unchanged
until day 21, at which point each rat was perturbed with
PBS, LPS, or rhIL-6. In PBS control rats, plasma tracer was
reduced slightly for the duration of the treatment period
(7 days). In rats treated with LPS, there was a rapid reduction in plasma tracer that reached a nadir by ?2 days and
then increased to preperturbation levels by 6 days. In rats
treated with rhIL-6, there was an even more rapid and
larger reduction than in LPS-treated rats. This reduction
in tracer persisted for ?8 days, when it started to return to
preperturbation levels. After the perturbation, the terminal slope was less shallow compared with the preperturbation terminal slope.
Specific activity of tracer and tracee
The specific activity of tracer in plasma (the ratio of the
fdose to the concentration of plasma retinol) is shown
in Fig. 3. Before inflammation, changes in plasma retinol specific activity were similar for the three groups. The
specific activity in both LPS- and rhIL-6-treated rats decreased at the beginning of inflammation and returned to
PBS control levels after inflammation.
Kinetic analysis: absorption and processing of the tracer
Compartmental analysis of group mean data using
the WinSAAM computer program was applied to develop
steady-state models of VA kinetics based on data for the
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Kinetic study: dynamics of retinol (tracee)
Hyporetinolemia was observed in rats treat with LPS
(242% plasma retinol concentrations relative to controls;
P 5 0.0004) or rhIL-6 (257% plasma retinol concentrations relative to controls; P 5 0.0002). Note that retinol
concentrations in PBS controls decreased by ?16% at
3 days after surgery (P 5 0.14) (Fig. 2). The fraction of
[3H]VA in plasma decreased during inflammation and
returned to control levels after 6 days in LPS-treated rats
and after 16 days in rhIL-6-treated rats. In contrast to effects related to inflammation, plasma concentrations of
retinol before and after perturbation were the same within
each group, as indicated by the slope of the line describing
this change (P . 0.20).

Fig. 2. Plasma retinol concentrations in PBS-, LPS-, and rhIL-6treated rats. A: PBS, control. B: LPS. C: rhIL-6. Numbers represent
rat identification numbers. Curves represent smooth lines through
averaged data at each time point.

first 21 days (Fig. 4). A four-compartment preabsorption
and chylomicron-processing model was necessary to follow the behavior of the orally administered tracer (Fig. 4,
open circles). This is represented in the initial increase in
plasma tracer in the first 6 h after oral dosing. The radioactive tracer entered the system through compartment 1,
labeled with the asterisk. After moving into compartment 2,
a fraction of the tracer was irreversibly lost from the system. The remaining fraction entered compartment 3 and
Inflammation decreases hepatic mobilization of vitamin A
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TABLE 1. Compartment masses, transfer rates, plasma fractional
catabolic rates, and absorption efficiencies predicted by the absorption
and three-compartment model of vitamin A metabolism for PBS-, LPS-,
and rhIL-6-treated rats before perturbation
Treatment Groups
Parameter

Fig. 3. Plasma retinol specific activity in PBS-, LPS-, and rhIL-6treated rats. Specific activity was calculated as the fraction of the oral
dose (fdose) divided by the plasma retinol concentration (ROHp)
at each time point. Curves represent smooth lines through data
averaged at each time point. The vertical dashed line represents the
time at which PBS, LPS, or rhIL-6 was initially administered.

Kinetic analysis: three-compartment
model (preperturbation)
The preperturbation models were based on data from
the first 21 days of the experiment. Once the tracer was
absorbed, processed, and entered the plasma, the kinetics
of whole-body VA was analyzed using a three-compartment
model (Fig. 4, closed circles). These three compartments
were represented largely by plasma (compartment 5), kidneys/
interstitial fluid (compartment 6; fast turning-over pool),

LPS

rhIL-6

14.34
3.45
59.73
2.44
39.12
64.27
370.22
149.75
36.06
36.06
36.06
113.70
516.02
516.02
155.22
119.17
36.06
0.92
24.10

6.53
1.49
1.33
2.01
35.44
53.16
324.29
139.08
31.79
31.79
31.79
107.29
425.29
425.29
125.30
93.51
31.79
0.90
22.90

7.53
2.04
1.02
5.27
33.77
50.96
431.03
148.19
40.11
40.11
40.11
108.08
430.81
430.81
143.44
103.33
40.11
1.19
27.10

LPS, lipopolysaccharide; M, mass; R, transfer rate; rhIL-6, recombinant human interleukin-6.

and liver and carcass (compartment 7; slow turning-over
pool), as hypothesized by two of the authors (30). Postabsorption irreversible loss or utilization (e.g., through catabolism and metabolism) occurred in the slow turning-over
pool and thus was represented by movement into the irreversible loss pool (compartment 10). To estimate compartment masses and transfer rates, the calculated plasma retinol
pool size was entered into the model. The parameters
estimated for the preperturbation model’s compartment
masses [M(I)], transfer rates [R(I,J)], plasma fractional
catabolic rates, and system disposal rates [R(10,7)] are
listed in Table 1.
The predicted model clearly fits the preperturbation
data but not the remaining data for each treatment group

Fig. 4. Working compartmental model developed to fit
tracer data from plasma for LPS-treated rats. Circles represent compartments, and arrows represent adjustable
model parameters {fractional transfer coefficients [L(I,J)],
or the fraction of compartment J’s tracer transferred to
compartment I each day}. Numbers in parentheses represent fractional transfer rates [R(I,J)] or the nmol of J’s
tracee transferred to compartment I each day. Numbers in
compartments 5, 6, and 7 represent compartment masses
[M(I)] or the nmol of tracee in each compartment. The
rectangle (3) represents a delay element included to explain chylomicron and hepatic VA processing. Tracer was
administered into compartment 1 (asterisk), and samples
were taken from the plasma or compartment 5 (triangle).
DT, delay time.
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represents the percentage of the dose absorbed (?23–
27%). Compartment 3 is a delay built into the model to
represent the biological processes of chylomicron and
hepatic retinyl ester metabolism. This processing or delay
lasted ?1 h. After this delay, the tracer entered compartment 4 and then immediately entered the postabsorption/
processing plasma pool (compartment 5).

M(1), nmol
M(2), nmol
M(3), nmol
M(4), nmol
M(5), nmol
M(6), nmol
M(7), nmol
R(2,1), nmol/day
R(3,2), nmol/day
R(4,3), nmol/day
R(5,4), nmol/day
R(10,2), nmol/day
R(6,5), nmol/day
R(5,6), nmol/day
R(7,5), nmol/day
R(5,7), nmol/day
R(10,7), nmol/day
Plasma fractional catabolic rate, day21
Absorption, %

PBS

(Fig. 5A–D). After the perturbation, the terminal slope was
slightly more shallow compared with the preperturbation
terminal slope. That is, the predicted amount of tracee
irreversibly leaving the system (i.e., disposal rate) decreased in response to the surgery and implantation of the
pump, from 36.1 to 17.1 nmol/day in the PBS group, from
31.8 to 27.2 nmol/day in the LPS group, and from 42.3 to
20.5 nmol/day in the rhIL-6 group. Because this reduction
occurred similarly in control rats and rats treated with LPS
or rhIL-6, it suggested an on or off response independent
of the relative severity of the inflammatory stimulus.

Fig. 5. Model-predicted curves of urinary excretion (A), increased irreversible loss (B), increased movement into interstitial fluid (C), and decreased hepatic mobilization (D) of VA in LPS-treated rats. Diamonds
represent observed data points (mean of five rats), and solid lines represent the model-predicted curve. The
vertical dotted lines represent the duration of LPS treatment (3 days). Circles represent kinetically distinct
compartments (5, plasma; 6, kidney/interstitium; 7, liver/carcass). The thin arrows represent unaltered
parameters, and the thick arrows represent added or adjusted parameters.
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Kinetic analysis: potential causes of hyporetinolemia
To model urinary excretion, irreversible loss was added
from the fast turning-over extravascular pool [compartment 6; L(10,6) (Fig. 5A)]. Even if the model was adjusted
so that all VA entering the fast turning-over pool was
irreversibly excreted, this did not adequately fit the
observed VA kinetics and dynamics. The same was true
when an increase in irreversible loss from the slow turningover pool was modeled (Fig. 5B). It may also have been
possible that VA moved into interstitial fluid during
inflammation. To model this phenomenon, a temporary
net input of VA into the fast turning-over extravascular
pool was applied (i.e., increased movement of VA out of
the blood into the fast turning-over pool and/or decreased movement of VA out of the fast turning-over pool
into blood) (Fig. 5C). This model fit better the observed
plasma VA kinetics and dynamics than the previous two
models. However, biologically, this model of inflammation-

induced hyporetinolemia was unlikely, because an elimination of irreversible loss of VA is required for this model
to fit the observed data. In contrast, a 79% reduced mobilization of hepatic retinol (from 4.3 to 0.9 nmol/h) by 15 h
best accounted for the observed changes in plasma VA
kinetics in the LPS group (Fig. 5D), which was modeled
using a two-part multiexponential difference equation.
Model parameter changes for these potential causes are
represented in Table 2. Changes to parameters in the
model were as follows: increased urinary excretion, add
L(10,6); increased irreversible loss, adjust L(10,7); increased movement into interstitial fluid, adjust L(6,5) and
L(5,6); and decreased hepatic mobilization of retinol,
adjust L(5,7). The sum of squares and the AIC number
indicated that the model that best fit the data was decreased hepatic mobilization.
The model of decreased hepatic mobilization of retinol
was then applied to kinetic data from rhIL-6-perturbed
rats. Similar to LPS treatment, the adjustment of one
parameter provided an adequate fit of the model to the
observed changes in tracer (Fig. 6). At the beginning of
the perturbation, an immediate reduction in L(5,7) accounted for the first 8 days since the perturbation. This
parameter decreased by ?75% (from 0.24 to 0.06 pools/
day) with rhIL-6 treatment compared with a reduction of
76% (from 0.29 to 0.07 pools/day) with LPS treatment
(Fig. 7). The maximum reduction caused by LPS took
?17.5 h versus ?5 h with rhIL-6 treatment. After 8 days,
the increasing portion of the exponential equation was
applied to account for the increase in observed plasma

TABLE 2. Sum of squares and changes in parameters to model increased urinary excretion, increased irreversible loss, increased movement into
interstitial fluid, and decreased hepatic mobilization in LPS-treated rats
Mechanism

Increased urinary excretion
Increased irreversible loss
Increased movement into interstitial fluid
Decreased hepatic mobilization

Parameter

Preperturbation Value

Perturbation
Value (day 0)

Postperturbation
Value (day 3)

Sum of Squares (Akaike’s
Information Criterion)

L(10,6)
L(10,7)
L(10,7)
L(5,6)
L(6,5)
L(10,7)
L(5,7)
L(10,7)

00.000
00.098
00.098
8.000
12.000
00.098
00.288
00.098

1.769
0.000
0.298
0.000
2.496
0.000
0.288 3 functiona
0.084

00.000
00.000
00.018
5.036
37.265
00.000

1.07 3 1025 (2381)
1.41 3 1025 (2375)
4.55 3 1026 (2404)
1.12 3 1026 (2450)

00.084

a
G(41) 5 (K(11) 3 EXP(2P(1) 3 TH) 1 K(12) 3 (22 (P(4) 3 (EXP(2P(2) 3 TH))) 2EXP(2P(3) 3 TH))). In this equation, 41 is an
arbitrary name; K indicates intercepts (exponential constants), P indicates slopes (exponential coefficients), T is time (days) since the administration of the tracer, and TH (theta) is a second independent variable representing time (days) since osmotic pump implantation. K(11) 5 1.145,
K(12) 5 0.855, P(1) 5 3.335, P(2) 5 0.405, P(3) 5 0.040, P(4) 5 1.169.

tracer. This increase occurred at a slightly faster rate in
the rhIL-6 model compared with the rate predicted by the
LPS model.

The association between infections and hyporetinolemia has been well documented in both clinical and nonclinical studies. However, these studies have had difficulty
assessing which is the prime driver because of the close
interaction between VA deficiency and infection-induced
inflammation. Even clinical studies, in which serial measurements of plasma retinol or urinary RBP have been used to
monitor the effect of infection-induced inflammation,
have not clearly determined the cause and consequences
of hyporetinolemia (31, 32). Experimental studies in animals have shown without exception that plasma retinol
can be reduced by a variety of immune stressors ranging
from viral infections and turpentine injections to prolonged
immobilization (32–36). These studies have suggested various mechanisms, including a decreased secretion of liver
RBP (33, 34), a reduced secretion of liver Transthyretin (35),

Fig. 6. Semilogarithmic plot of the model-predicted values of VA
kinetics before, during, and after rhIL-6-induced hyporetinolemia.
Diamonds represent observed data points (mean of five rats), and
the solid line represents the best-fit calculated model. The thick
arrow represents the adjusted parameter. Time bounded by the vertical dotted lines represents the duration of treatment.
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Fig. 7. Model-predicted changes in fractional transfer coefficients
over time in LPS- and rhIL-6-treated rats. The solid line represents
the predicted change in the fraction of compartment 7 transferred
to compartment 5 per day over time in LPS-treated rats. The dashed
line represents the predicted change for rhIL-6-treated rats. Compartment numbers are shown in the model in Fig. 4. The multiexponential difference equation for the model of LPS treatment is
given in Table 2. The equation for the model of rhIL-6 treatment
is G(41) 5 (K(11) 3 EXP(2P(1) 3 TH) 1 (K(12) 3 (2 2 (P(4) 3
((EXP(2P(2) 3 TH 3 TH)))) 2 EXP(2P(3) 3 TH 3 TH)))).
K(11) 5 2 2 1/P(4), K(12) 5 1/P(4), P(1) 5 1.895, P(2) 5 0.00717,
P(3) 5 0.0406, P(4) 5 0.981. TH, theta.
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DISCUSSION

and an increased utilization of plasma retinol (33, 36, 37).
However, these studies have not been able to answer questions about what, where, and how hyporetinolemia occurs
during inflammation. Even our own studies have been limited by providing a cross-sectional perspective of the changes
in plasma retinol among tissues during inflammation induced with LPS or rhIL-6 (9, 11). Because of this limitation,
we developed a kinetic study using labeled VA and mathematical modeling using WinSAAM.
In the kinetic study, rats received sufficient VA in the
diet to maintain growth and other normal functions yet
avoided the accumulation of total whole-body VA stores, as
described previously (23). The absorption of tracer was
estimated to range from 23% to 27%, lower than expected.
Once the tracer was absorbed, the calculated time for enterocyte and hepatic processing of chylomicrons before it
was secreted into plasma as the RBP-retinol complex averaged ?40.2 min, and four kinetically different compart-

These include an increased catabolism of VA, an increased
transcapillary escape rate, and an increased urinary excretion of retinol (41). To examine these possibilities, we used
the mean observed data from LPS-treated rats, because the
shape of the tracer curve during the perturbation was less
complex. The approach was to determine the smallest
necessary change in the model that would account for the
observed reduction in plasma tracer and the hyporetinolemia. Four possible models and their associated alteration(s) in parameters were tested (Table 2). The model
based on a reduction in the mobilization of retinol from
the liver into plasma best fit statistically the observed data
(Fig. 5–7, Table 2).
The calculated reduced mobilization was based on a
user-defined two-component multiexponential difference
equation (Fig. 7). The first part of the equation describes
the decrease in the parameter, and the second part represents the increase. The concept and basis for this equation are from a kinetic analysis performed previously (12),
and an exponential function was chosen, because the components might have biological meaning. From a biological perspective, hyporetinolemia caused by a decreased
hepatic mobilization of VA coincides with our previous
findings of a decrease in both protein and mRNA levels of
hepatic RBP and the accumulation of retinol and retinyl
esters in the liver in response to LPS or rhIL-6 (9, 11). The
prolonged hyporetinolemia caused by continuous rhIL-6
infusion was modeled by prolonging the reduction in the
rate of mobilization of VA from the liver into plasma.
Compared with LPS treatment, rhIL-6 caused a similar
but earlier reduction in the rate of mobilization (279% by
15 h for LPS vs. 275% by 5.6 h for IL-6). This reduction
was maintained for 8 days before retinol concentrations
increased to preperturbation levels in a manner similar
to the modeled increase in LPS-treated rats (Fig. 7). This
corroborates the concept that the effect of LPS on VA
metabolism is through its induction of IL-6 synthesis by
various immune cells, hence LPS’s delayed onset in the
reduction rate of mobilization. Subsequently, IL-6 presumably affects the VA system by decreasing hepatic RBP production (11).
In our previous experiments with LPS, we observed a
decrease in food intake, which was associated with a mild
and limiting reduction in plasma retinol (9). In the rhIL-6
model (11), we found that the continuous administration
of rhIL-6 for 7 days did not affect food intake significantly.
In the present experiments, we observed that LPS and
rhIL-6 decreased plasma retinol (Fig. 2), and in both cases
the compartmental analysis predicted a reduced mobilization in hepatic retinol (Fig. 7). These results suggest that
regardless of changes in food intake (LPS-induced anorexia vs. rhIL-6’s no effect on food intake), there was an
accumulation of VA in the liver.
In contrast, the increased irreversible utilization and urinary excretion models were inadequate to describe tracer
kinetics during the perturbation (Fig. 5, Table 2). It was
impossible to account for the dramatic decrease in plasma
retinol and its tracer by altering the parameters that represented these changes or to adequately increase plasma
Inflammation decreases hepatic mobilization of vitamin A
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ments were necessary to model this process (Fig. 4), as
shown previously (12). Once the tracer entered the plasma,
VA kinetics fit a three-compartment model proposed previously (23). In this model (Fig. 4), the central compartment
represents plasma retinol bound to RBP- Transthyretin.
Although in all animals, tracer had equilibrated with body
pools of VA within 10 days after dose administration
(Fig. 3A), inflammation was not induced until 21 days to
ensure that the dose was highly equilibrated with wholebody pools; then, a control model could be identified. As
expected, the parameters representing the preperturbation
models for PBS, LPS, and rhIL-6 treatments were similar,
because at this point all animals had been treated similarly.
Irreversible utilization of VA averaged 36 nmol/day, which
was greater than the 27 nmol/day that we estimated rats
were consuming, suggesting that these animals were in a
negative VA balance (e.g., marginal VA deficiency).
Whole-body VA metabolism was perturbed by surgery
(implantation of osmotic minipumps) and then continuous administration of LPS or rhIL-6. The reduction of
plasma retinol in PBS control rats was likely attributable to
the surgery and implantation of the minipump and was
self-limiting and not as substantial as that caused by either
LPS or rhIL-6 (Fig. 2). It is interesting that although the
duration of LPS treatment was 3 days, the plasma retinol
nadir occurred after ?1 day of treatment and then increased rapidly thereafter. In contrast, 7 days of rhIL-6
treatment caused a large reduction in plasma retinol concentration that was sustained to 10 days (3 days beyond the
end of treatment) before increasing rapidly. These differences reflected the tolerance to endotoxin induced by
repeated or continuous LPS dosing (38) and confirmed
the appropriateness of using rhIL-6 to maintain the acutephase response of inflammation in a model of prolonged
hyporetinolemia (11). It is noteworthy that a long-lasting
effect of IL-6 in inducing hyporetinolemia has been observed in clinical studies of infections caused by respiratory
syncytial virus or measles virus (39, 40). Plasma retinol
concentrations before and after hyporetinolemia were not
significantly different in either of the treatment groups,
suggesting that plasma retinol rebounds from inflammationinduced hyporetinolemia when the inflammatory stimulus
is no longer present. In this regard, the study design allowed for the preperturbation and postperturbation comparison within each group.
Similarly, plasma tracer concentrations were affected
more by LPS or rhIL-6 treatments than by surgery. Mathematical modeling using WinSAAM revealed that the effect
of inflammation was acute and transitory. Although the
reductions in plasma tracer paralleled the observed hyporetinolemia, the specific activity (the ratio of tracer to
tracee) decreased during the perturbation with LPS or
rhIL-6 (Fig. 3). This observation has significant implications for the use of a stable isotope dilution technique to
measure VA status (28): if inflammation reduces plasma
retinol specific activity, the stable isotope dilution technique will be less accurate.
As indicated above, several mechanisms have been proposed to explain inflammation-induced hyporetinolemia.

This work is part of a doctoral thesis by S.H.G. and was supported by a grant from the National Institutes of Health, National
Institute of Diabetes and Digestive and Kidney Diseases (RO3
DK-062166 to F.J.R.).
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tracer concentrations once the perturbation was complete. For these postulated mechanisms, both the time
(initiation, termination, and duration) and magnitude of
the parameters were altered to attempt to account for the
observed changes; however, these modifications did not
improve the fit of the observed to the calculated data
(Fig. 5). Comparatively, the hypothesis of increased movement into interstitial fluid provided a closer fit to the observed data (Fig. 5). Here, the size of the pool of VA in
the fast turning-over extravascular compartment may have
provided a site where VA could transiently move during
inflammation, possibly as a result of an associated increase
in vascular permeability. If this were the case, however, we
would likely also have observed decreases in other similarly sized blood constituents in response to inflammation. Nonetheless, this model did not perfectly fit the
observed data and therefore was judged not to be a major contributor to inflammation-induced hyporetinolemia
(Table 2; AIC number 2404 vs. 2450 for decreased hepatic mobilization).
In summary, these findings and their interpretation indicate that inflammation-induced hyporetinolemia can be
caused by trauma (i.e., surgery) or by bacterial or viral
infections (i.e., LPS or rhIL-6). The duration and extent
of the hyporetinolemia depend on the type of immune
stressor. Based on our data, we conclude that the most
likely underlying mechanism is a reduced synthesis of
hepatic RBP (9, 11). Consequently, there is a reduced
mobilization or an accumulation of hepatic VA, in part
attributable to a reduced recycling of retinol from liver
stellate cell retinyl ester stores back into plasma and from
impairing the hepatic secretion of recently absorbed dietary VA. Both hyporetinolemia and the accumulation of
hepatic VA reduce the availability of VA to extrahepatic
tissues, especially those that depend on retinol bound
to RBP. In this regard, these findings help to clarify the
severity of measles infection and its amelioration with
large doses of VA (i.e., 200,000 IU/day on 2 consecutive
days) in VA-deficient children.

28. Furr, H. C., M. H. Green, M. Haskell, N. Mokhtar, P. Nestel, S.
Newton, J. D. Ribaya-Mercado, G. Tang, S. Tanumihardjo, and E.
Wasantwisut. 2005. Stable isotope dilution techniques for assessing
vitamin A status and bioefficacy of provitamin A carotenoids in
humans. Public Health Nutr. 8: 596–607.
29. Akaike, H. 1974. A new look at the Statistical Model Identification.
IEEE Trans. Automat. Control. 19: 716–723.
30. Green, M. H., J. B. Green, T. Berg, K. R. Norum, and R. Blomhoff.
1993. Vitamin A metabolism in rat liver: a kinetic model. Am. J.
Physiol. 264: G509–G521.
31. Ramsden, D. B., H. P. Prince, W. A. Burr, A. R. Bradwell, E. G.
Black, A. E. Evans, and R. Hoffenberg. 1978. The inter-relationship
of thyroid hormones, vitamin A and their binding proteins following acute stress. Clin. Endocrinol. (Oxf.). 8: 109–122.
32. Mitra, A. K., M. A. Wahed, A. K. Chowdhury, and C. B. Stephensen.
2002. Urinary retinol excretion in children with acute watery
diarrhoea. J. Health Popul. Nutr. 20: 12–17.
33. Sijtsma, S. R., C. E. West, J. H. Rombout, and A. J. Van der Zijpp.
1989. Effect of Newcastle disease virus infection on vitamin A
metabolism in chickens. J. Nutr. 119: 940–947.
34. Takase, S., T. Goda, H. Yokogoshi, and T. Hoshi. 1991. Effects of
various dietary protein contents on vitamin A status of rats exposed

35.
36.
37.
38.
39.
40.
41.

to prolonged immobilization through suspension. J. Nutr. Sci.
Vitaminol. (Tokyo). 37: 443–452.
Felding, P., and G. Fex. 1985. Rates of synthesis of prealbumin and
retinol-binding protein during acute inflammation in the rat. Acta
Physiol. Scand. 123: 477–483.
West, C. E., S. R. Sijtsma, B. Kouwenhoven, J. H. Rombout, and
A. J. van der Zijpp. 1992. Epithelia-damaging virus infections affect
vitamin A status in chickens. J. Nutr. 122: 333–339.
Kanda, Y., N. Yamamoto, and Y. Yoshino. 1990. Utilization of
vitamin A in rats with inflammation. Biochim. Biophys. Acta. 1034:
337–341.
Dominguez Fernandez, E., S. Flohe, F. Siemers, M. Nau, and F. U.
Schade. 2002. Endotoxin tolerance in rats: influence on LPS-induced
changes in excretory liver function. Inflamm. Res. 51: 500–505.
Neuzil, K. M., W. C. Gruber, F. Chytil, M. T. Stahlman, B.
Engelhardt, and B. S. Graham. 1994. Serum vitamin A levels in
respiratory syncytial virus infection. J. Pediatr. 124: 433–436.
Rosales, F. J., C. Kjolhede, and S. Goodman. 1996. Efficacy of a
single oral dose of 200,000 IU of oil-soluble vitamin A in measlesassociated morbidity. Am. J. Epidemiol. 143: 413–422.
Tomkins, A. 2003. Assessing micronutrient status in the presence of
inflammation. J. Nutr. 133 (Suppl.): 1649–1655.

Downloaded from www.jlr.org by guest, on October 12, 2017

Inflammation decreases hepatic mobilization of vitamin A

913

